Status:
COMPLETED
Gemcitabine With Curcumin for Pancreatic Cancer
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The study hypotheasis is that curcumin, a natural compound with a potent antiproliferative effect, can improve the efficacy of the standard chemotherapy gemcitabine in patients with advanced pancreati...
Eligibility Criteria
Inclusion
- locally advanced or metastatic adenocarcinoma of the pancreas
- no prior chemotherapy
- performance status 0-2
- adequate hematology and chemistry
Exclusion
- serious concurrent medical condition
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00192842
Start Date
July 1 2004
End Date
September 1 2010
Last Update
September 22 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.